Lyell Immunopharma, Inc. (LYEL)
24.55
+0.25
(+1.03%)
USD |
NASDAQ |
Jan 09, 16:00
24.56
+0.01
(+0.04%)
After-Hours: 20:00
Lyell Immunopharma Total Liabilities (Quarterly): 78.84M for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Insmed, Inc. | 1.415B |
| Nektar Therapeutics | 216.26M |
| GT Biopharma, Inc. | 1.321M |
| Ionis Pharmaceuticals, Inc. | 2.415B |
| Regeneron Pharmaceuticals, Inc. | 9.212B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 407.96M |
| Shareholders Equity (Quarterly) | 329.12M |
| Debt to Equity Ratio | 0.1613 |
| Current Ratio | 10.30 |
| Net Debt Paydown Yield | 0.59% |